PMID: 42417199

Real-World vs. Randomized Trial Evidence for Incretin-Based Therapies: A Narrative Review.

Bloomgarden Zachary

Journal of diabetes · 2026

Vol. 18, Issue 7, pp. e70248

View on PubMedDOI

This entry links to third-party literature. For research use only.

HumansIncretinsDiabetes Mellitus, Type 2Randomized Controlled Trials as TopicHypoglycemic AgentsSemaglutideWeight LossGlucagon-Like PeptidesTirzepatideObesity

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.